BHB supplement study for familial adenomatous polyposis
Part of Cancer, Digestive system, Genetic & congenital clinical trials.
This trial tests whether taking a supplement called beta-hydroxybutyrate (BHB) can help prevent polyps in people with familial adenomatous polyposis (FAP), a condition that causes many polyps in the colon. The study has two parts: one for people who have already had colon surgery, and another for those who still have their colon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have FAP with a confirmed APC gene change, or have a strong family history of FAP.
- You must be 18 or older and not pregnant.
- You cannot have had all of your colon and rectum removed with a permanent ileostomy.
- You cannot have diabetes treated with medication, active cancer treatment, or advanced kidney disease.
- You cannot be following a ketogenic diet or intermittent fasting for the 4 weeks before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial studies REC-4881 in adults with familial adenomatous polyposis (FAP), a condition that causes many colon/rectum and duodenal polyps. It aims to see whether the treatment can safely help control or shrink polyp growth in people who have had bowel surgery.
This trial tests a new drug, TPST-1495, to reduce the number of benign polyps in the small intestine for people with a condition called familial adenomatous polyposis (FAP). If you join, you will likely not know if you receive the drug or a placebo, to see if the drug is helpful.
This trial tests whether a home-based exercise program can help people with familial adenomatous polyposis (FAP) who have rectal polyps. You may qualify if you have FAP, have not had your rectum removed, have at least 5 rectal polyps larger than 2 mm, and are currently inactive.
This study tracks how colorectal polyps develop in people with familial adenomatous polyposis (FAP), a genetic condition that causes many polyps. It aims to better understand and possibly prevent cancer, without immediate surgery.
This trial studies a tailored plan for surveillance (check-ups) and interventions to find and remove new growths early in people with familial adenomatous polyposis (FAP) after bowel surgery. It may help lower the chance of cancer by closely monitoring and treating polyps when they appear.
This trial tests a personalized plan for regularly checking and treating stomach and first-part of intestine polyps in people with familial adenomatous polyposis (FAP). It may help by catching problems early and choosing the right intervention at the right time.
Hear when a new FAP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.